Paul H Duray
Overview
Explore the profile of Paul H Duray including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
1187
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Barnhill R, Argenyi Z, Berwick M, Duray P, Erickson L, Guitart J, et al.
Am J Surg Pathol
. 2007 Dec;
32(1):36-44.
PMID: 18162768
The distinction of cellular blue nevi (CBN) with atypical features ["atypical" CBN (ACBN)] from conventional CBN and malignant melanomas related to or derived from CBN remains a difficult problem. Here,...
2.
Iqbal J, He G, Biesecker L, Rosen P, Duray P, Schwartzentruber D, et al.
Ann Clin Lab Sci
. 2006 Nov;
36(4):469-74.
PMID: 17127737
Proteus syndrome (PS) is a severe, variable, and rare disorder with asymmetric and disproportionate overgrowth of body parts, cerebriform connective tissue nevi, epidermal nevi, dysregulated adipose tissue, and vascular malformations....
3.
Cassarino D, Miller W, Auerbach A, Yang A, Sherry R, Duray P
J Cutan Pathol
. 2006 Apr;
33(5):335-42.
PMID: 16640539
Background: A new approach to prevent disease recurrence in high-risk melanoma patients involves immunization with gp100 and tyrosinase peptides. This is the first study to examine the effects of such...
4.
Baird K, Davis S, Antonescu C, Harper U, Walker R, Chen Y, et al.
Cancer Res
. 2005 Oct;
65(20):9226-35.
PMID: 16230383
Sarcomas are a biologically complex group of tumors of mesenchymal origin. By using gene expression microarray analysis, we aimed to find clues into the cellular differentiation and oncogenic pathways active...
5.
Best C, Gillespie J, Yi Y, Chandramouli G, Perlmutter M, Gathright Y, et al.
Clin Cancer Res
. 2005 Oct;
11(19 Pt 1):6823-34.
PMID: 16203770
Purpose: After an initial response to androgen ablation, most prostate tumors recur, ultimately progressing to highly aggressive androgen-independent cancer. The molecular mechanisms underlying progression are not well known in part...
6.
Duray P, Yin S, Ito Y, Bezrukov L, Cox C, Cho M, et al.
J Infect Dis
. 2005 Apr;
191(10):1747-54.
PMID: 15838803
Borrelia burgdorferi sensu stricto is an etiological agent of Lyme disease. The lack of an adequate ex vivo system for human tissue infection is an obstacle to fully understanding the...
7.
Weeraratna A, Becker D, Carr K, Duray P, Rosenblatt K, Yang S, et al.
Oncogene
. 2004 Feb;
23(12):2264-74.
PMID: 14755246
In this study, we generated three SAGE libraries from melanoma tissues. Using bioinformatics tools usually applied to microarray data, we identified several genes, including novel transcripts, which are preferentially expressed...
8.
Cassarino D, Fullen D, Sondak V, Duray P
J Cutan Pathol
. 2004 Jan;
30(10):647-51.
PMID: 14744091
Background: Childhood melanoma is a rare and controversial diagnosis. Methods: We present the case of a 4 1/2-year-old child found to have an expanding, elevated pigmented lesion on her back....
9.
Cassarino D, Quezado M, Ghatak N, Duray P
Arch Pathol Lab Med
. 2003 Aug;
127(9):1204-6.
PMID: 12946221
Neurological complications of Lyme disease include meningitis, encephalitis, dementia, and, rarely, parkinsonism. We present a case of striatonigral degeneration, a form of multiple system atrophy, in Lyme-associated parkinsonism. A 63-year-old...
10.
Prieto V, Argenyi Z, Barnhill R, Duray P, Elenitsas R, From L, et al.
Am J Clin Pathol
. 2003 Aug;
120(2):203-8.
PMID: 12931550
To assess the diagnostic accuracy of margin evaluation of melanocytic lesions using en face frozen sections compared with standard paraffin-embedded sections, we studied 2 sets of lesions in which en...